Healthcare provider profile · identity verified

Mitchell Erik Kramer, MD

Family Practice · SILVIS, IL · NPI 1750842704

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1085	312
Losartan Potassium	Losartan Potassium	602	167
Levothyroxine Sodium	Levothyroxine Sodium	457	124
Amlodipine Besylate	Amlodipine Besylate	447	121
Lisinopril	Lisinopril	362	101
Rosuvastatin Calcium	Rosuvastatin Calcium	278	83
Gabapentin	Gabapentin	265	70
Pantoprazole Sodium	Pantoprazole Sodium	261	85
Metformin Hcl Er	Metformin Hcl	257	80
Metoprolol Succinate	Metoprolol Succinate	253	66
Sertraline Hcl	Sertraline Hcl	244	63
Hydrochlorothiazide	Hydrochlorothiazide	232	74
Furosemide	Furosemide	231	62
Tamsulosin Hcl	Tamsulosin Hcl	212	68
Metformin Hcl	Metformin Hcl	197	56
Albuterol Sulfate Hfa	Albuterol Sulfate	193	81
Omeprazole	Omeprazole	185	59
Jardiance	Empagliflozin	172	53
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	159	67
Alprazolam	Alprazolam	144	39
Tramadol Hcl	Tramadol Hcl	123	29
Clopidogrel	Clopidogrel Bisulfate	118	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	116	22
Allopurinol	Allopurinol	115	32
Duloxetine Hcl	Duloxetine Hcl	113	33
Potassium Chloride	Potassium Chloride	112	29
Simvastatin	Simvastatin	110	36
Alendronate Sodium	Alendronate Sodium	104	29
Montelukast Sodium	Montelukast Sodium	104	31
Glipizide Er	Glipizide	103	29
Metoprolol Tartrate	Metoprolol Tartrate	101	23
Pravastatin Sodium	Pravastatin Sodium	99	27
Prednisone	Prednisone	90	71
Trazodone Hcl	Trazodone Hcl	83	23
Clonazepam	Clonazepam	79	18
Meloxicam	Meloxicam	78	22
Ozempic	Semaglutide	78	14
Fluticasone Propionate	Fluticasone Propionate	76	28
Lorazepam	Lorazepam	75	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	70	63
Oxycodone Hcl	Oxycodone Hcl	67	suppressed
Eliquis	Apixaban	65	22
Glipizide	Glipizide	65	21
Trulicity	Dulaglutide	64	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	59	47
Pregabalin	Pregabalin	57	15
Carvedilol	Carvedilol	55	21
Irbesartan	Irbesartan	54	14
Mounjaro	Tirzepatide	52	suppressed
Azithromycin	Azithromycin	50	46
Glimepiride	Glimepiride	50	suppressed
Donepezil Hcl	Donepezil Hcl	49	suppressed
Finasteride	Finasteride	47	15
Pioglitazone Hcl	Pioglitazone Hcl	46	14
Ropinirole Hcl	Ropinirole Hcl	44	12
Amitriptyline Hcl	Amitriptyline Hcl	42	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Paroxetine Hcl	Paroxetine Hcl	41	11
Ezetimibe	Ezetimibe	40	12
Ibuprofen	Ibuprofen	39	16
Methylprednisolone	Methylprednisolone	39	35
Cephalexin	Cephalexin	38	13
Enalapril Maleate	Enalapril Maleate	38	suppressed
Levetiracetam	Levetiracetam	38	suppressed
Ondansetron Odt	Ondansetron	38	20
Symbicort	Budesonide/Formoterol Fumarate	38	suppressed
Nifedipine Er	Nifedipine	37	suppressed
Spironolactone	Spironolactone	37	14
Esomeprazole Magnesium	Esomeprazole Magnesium	36	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	12
Memantine Hcl	Memantine Hcl	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	12
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Spiriva Handihaler	Tiotropium Bromide	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Famotidine	Famotidine	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Levofloxacin	Levofloxacin	30	28
Meclizine Hcl	Meclizine Hcl	30	14
Januvia	Sitagliptin Phosphate	29	suppressed
Atenolol	Atenolol	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Baclofen	Baclofen	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Rivastigmine	Rivastigmine Tartrate	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Minocycline Hcl	Minocycline Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Nabumetone	Nabumetone	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	12
Celecoxib	Celecoxib	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	15
Fentanyl	Fentanyl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Levemir Flexpen	Insulin Detemir	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Estradiol	Estradiol	18	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Clotrimazole	Clotrimazole	16	12
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Indapamide	Indapamide	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Trimethoprim	Trimethoprim	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	11
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Qnasl	Beclomethasone Dipropionate	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Torsemide	Torsemide	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed
Xtampza Er	Oxycodone Myristate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error